Abstract:A novel series of 4-arylsulfonyl-1,3-oxazoles have been synthesized and characterized by IR, 1H NMR, 13C NMR spectroscopy, elemental analysis, and chromato-mass-spectrometry. The anticancer activities of all the newly synthesized compounds were evaluated via a single high dose (10 μM) against 59 cancer cell lines (without Melanoma SK-MEL-5) by the National Cancer Institute according to its screening protocol. Among these compounds, 2-[4-(4-chlorophenyl)sulfonyl-2-phenyl-oxazol-5-yl]sulfanyl-N-(2,4-dimethoxyphenyl)acetamide exhibited the highest activity against lines SNB75 and SF-539 of the CNS Cancer subpanel present in Glioblastoma and Gliosarcoma, respectively, exerting a cytostatic effect. 2-[4-(4-Bromophenyl)sulfonyl-2-phenyl-oxazol-5-yl]sulfanylacetamide has the highest antiproliferative activity against the HOP-92 (carcinoma) of the Non-Small Cell Lung Cancer subpanel, while N-(4-ethoxyphenyl)-2-[2-phenyl-4-(p-tolylsulfonyl)oxazol-5-yl]sulfanyl-acetamide exhibits cytotoxic activity against NCI-H226 (pleural mesothelioma) the Lung subpanel. The COMPARE analysis showed that the average graphs of the tested compounds have a weak or slightly moderate positive correlation with compounds with a known mechanism of antitumor activity, suggesting its specificity. These compounds demonstrated the anticancer activity against different individual cancer cell lines. This makes it possible to consider it a leading compound for further in-depth studies and synthesis of new 4-arylsulfonyl-1,3-derivatives oxazole with antitumor activity.

Synthesis of 2‐(pyridylvinyl)chromen‐4‐ones and their N‐oxide analogs for assessment of their biological activities as anticancer agents

Synthesis, Crystal Structure and Evaluation of Cancer Inhibitory Activity of 4-[Indol-3-yl-methylene]-1h-pyrazol-5(4h)-one Derivatives

Synthesis and Antitumor Activity of 2-Aryl-1, 2, 4-Triazolo[1, 5-A] Pyridine Derivatives

Synthesis of Flavone Derivatives via N-Amination and Evaluation of Their Anticancer Activities

Synthesis of quinoxalines and assessment of their inhibitory effects against human non-small-cell lung cancer cells

Synthesis And Biological Evaluation Of 3-Aryl-Quinoxaline-2-Carbonitrile 1,4-Di-N-Oxide Derivatives As Hypoxic Selective Anti-Tumor Agents

Synthesis of Novel Spin-Labeled Derivatives of 5-FU As Potential Antineoplastic Agents

Antitumor Agents 288: Design, Synthesis, SAR, and Biological Studies of Novel Heteroatom-Incorporated Antofine and Cryptopleurine Analogues As Potent and Selective Antitumor Agents.

Synthesis and Biological Evaluation of 3-Aryl-quinoxaline-2-carbonitrile 1,4-Di-<em>N</em>-oxide Derivatives as Hypoxic Selective Anti-tumor Agents

Synthesis and in Vitro Anticancer Activity of 6,7-Methylenedioxy (or 5-Hydroxy-6-methoxy)-2-(substituted Selenophenyl)Quinolin-4-One Analogs

Novel 5-Methyl-2,4-disubstitued-oxazole Derivatives: Synthesis and Anticancer Activity

Synthesis, Characterization, and in Vitro Anticancer Evaluation of 2-Aryl-4-Arylsulfonyl-5-RS-1,3-Oxazoles

Novel 3-(2-(3-methyl-5-substituted-phenyl-4,5-dihydropyrazol-1-yl)-2-oxoethoxy)-2-substituted-phenyl-4H-chromen-4-one: synthesis and anticancer activity.

Synthesis and biological evaluation of novel podophyllotoxin analogs as antitumor agents.

Design, Syntheses, and Antitumor Activity of Novel Chromone and Aurone Derivatives.

Design and synthesis of unsymmetric benzils, quinoxalines, and evaluations of their anticancer activities against human non‐small lung cancer cells

Synthesis of Flavonols and Assessment of Their Biological Activity as Anticancer Agents

Synthesis of selenophene‐containing flavonols and 2‐styrylchromones: Evaluation of their activities compared with selenophene‐containing chalcones as potential anticancer agents

Synthesis and anticancer activity of new spirooxindoles incorporating[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine moiety

Synthesis and biological evaluation of novel Jiyuan Oridonin A-1,2,3-triazole-azole derivatives as antiproliferative agents.

Novel 5-Methyl-2-[(un)substituted Phenyl]-4-{4,5-Dihydro-3-[(Un)Substituted Phenyl]-5-(1,2,3,4-Tetrahydroisoquinoline-2-Yl)Pyrazol-1-Yl}-Oxazole Derivatives: Synthesis and Anticancer Activity